Market Resilience: Nasdaq 100 Rebounds Amid Global Tensions

The Nasdaq 100 index rose 1.58% on Monday, June 8, 2026, closing at 29,414.26 points as investors returned to technology stocks following a significant sell-off. Despite ongoing geopolitical instability in the Middle East and rising oil prices, the broader market showed signs of recovery, with the S&P 500 climbing 0.30% to 7,405.73 points. Conversely, the Dow Jones Industrial Average experienced a slight decline of 0.16%, ending the session at 50,786.01 points.

Drivers of the Tech Sector Recovery

The technology sector’s rebound was largely fueled by specific corporate developments rather than broad macroeconomic shifts. Intel shares jumped 11.2% following reports that Alphabet, Google’s parent company, selected Intel to manufacture over 3 million of its specialized artificial intelligence chips, known as Tensor Processing Units (TPUs). According to reporting by The Information, this partnership follows months of rigorous testing by the tech giant.

Semiconductor stocks, which had faced heavy selling pressure the previous week, were among the day’s top performers. Marvell Technology saw its shares increase by 9.6% after the company was slated for inclusion in the S&P 500 index, effective June 22. It will replace Campbell’s, which saw its own shares dip 0.9% despite reporting positive quarterly earnings.

Market Outlook and Analyst Perspectives

Market strategists at Morgan Stanley characterized the previous week’s market downturn as a healthy and necessary correction. Maintaining a positive outlook, the firm projects the S&P 500 could reach 8,000 points this year, representing a potential gain of nearly 17%. Citigroup analysts remain even more optimistic, having raised their year-end target for the S&P 500 to 8,100 points.

While the broader market remains focused on corporate profits and economic data, the geopolitical situation continues to influence sentiment. Following a recent exchange of fire, leaders in Israel and Iran signaled a pause in direct hostilities, a development noted by Israeli Prime Minister Benjamin Netanyahu. This temporary de-escalation provided a degree of stability for traders navigating the start of the week.

Developments in Pharmaceuticals and AI

Outside of the technology index, the healthcare sector drew attention through data regarding weight-loss treatments. Eli Lilly shares rose 1.6% after the company presented data suggesting its drug, Retatrutide, could help patients lose 30% of their body weight over approximately two years. Meanwhile, competitor Novo Nordisk reported that its obesity medication, Wegovy, has surpassed 3 million prescriptions.

In the tech space, Apple shares fell 1.9% following the company’s developer conference. Despite the introduction of a new AI-driven system and an upgraded Siri assistant, investor reaction remained mixed, and the stock failed to sustain its brief climb to a record high during the presentation.

Key Takeaways

• Nasdaq 100 Performance: The index recovered 1.58% on Monday, reversing some of the losses sustained during the previous week’s sharp decline.
• Intel and Alphabet: Intel surged 11.2% on news of a major manufacturing contract for Google’s proprietary AI chips.
• S&P 500 Outlook: Major financial institutions including Morgan Stanley and Citigroup maintain optimistic year-end targets for the S&P 500, citing robust economic data.
• Pharma Growth: Eli Lilly and Novo Nordisk continue to dominate headlines in the pharmaceutical sector, with significant progress reported in their respective obesity treatment pipelines.